353 related articles for article (PubMed ID: 14984079)
21. Combination of ICSs and LABAs should be used in the management of patients with COPD - the con argument.
Road J
Can Respir J; 2004 Apr; 11(3):224-6. PubMed ID: 15124043
[No Abstract] [Full Text] [Related]
22. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
Diamant Z; Dekhuijzen PN
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
[TBL] [Abstract][Full Text] [Related]
23. Emerging therapeutic options for asthma.
Colice GL
Am J Manag Care; 2011 Apr; 17 Suppl 3():S82-9. PubMed ID: 21761958
[TBL] [Abstract][Full Text] [Related]
24. Leukotriene-receptor antagonists. Role in asthma management.
D'Urzo AD; Chapman KR
Can Fam Physician; 2000 Apr; 46():872-9. PubMed ID: 10790819
[TBL] [Abstract][Full Text] [Related]
25. Defining the effects of an inhaled corticosteroid and long-acting beta-agonist on therapeutic targets.
Settipane RA;
Allergy Asthma Proc; 2003; 24(2):85-9. PubMed ID: 12776440
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease.
Sin DD; Johnson M; Gan WQ; Man SF
Curr Pharm Des; 2004; 10(28):3547-60. PubMed ID: 15579052
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
O'Byrne PM; Gauvreau GM; Murphy DM
J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
[TBL] [Abstract][Full Text] [Related]
28. Compliance therapy with anti-inflammatory antiasthmatic drugs: inhaled corticosteroids and leukotriene receptor antagonists.
Riccioni G; Bucciarelli T; Mancini B; Di Ilio E; Palumbo G; D'Orazio N
Clin Ter; 2007; 158(4):363-70. PubMed ID: 17953289
[TBL] [Abstract][Full Text] [Related]
29. Long-acting beta2-agonists in asthma: an overview of Cochrane systematic reviews.
Walters JA; Wood-Baker R; Walters EH
Respir Med; 2005 Apr; 99(4):384-95. PubMed ID: 15763443
[TBL] [Abstract][Full Text] [Related]
30. Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling.
Hoshino M
Clin Rev Allergy Immunol; 2004 Aug; 27(1):59-64. PubMed ID: 15347851
[TBL] [Abstract][Full Text] [Related]
31. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
Holimon TD; Chafin CC; Self TH
Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
[TBL] [Abstract][Full Text] [Related]
32. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
33. Combination of ICSs and LABAs should be used in the management of patients with COPD--the pro argument.
Sin DD
Can Respir J; 2004 Apr; 11(3):221-3. PubMed ID: 15124042
[No Abstract] [Full Text] [Related]
34. Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.
Currie GP; Lee DK; Menzies D; Lipworth BJ
Chest; 2006 Jul; 130(1):301-2. PubMed ID: 16840420
[No Abstract] [Full Text] [Related]
35. Long-acting bronchodilator or leukotriene modifier as add-on therapy to inhaled corticosteroids in persistent asthma?
Currie GP; Lee DK; Srivastava P
Chest; 2005 Oct; 128(4):2954-62. PubMed ID: 16236972
[TBL] [Abstract][Full Text] [Related]
36. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
Hizawa N
Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
[TBL] [Abstract][Full Text] [Related]
37. Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease.
Johnson M
Proc Am Thorac Soc; 2004; 1(3):200-6. PubMed ID: 16113435
[TBL] [Abstract][Full Text] [Related]
38. A Comparison of Leukotriene Receptor Antagonists to Low-Dose Inhaled Corticosteroids in the Elderly with Mild Asthma.
Hong SH; Kang HR; Nam JH; Park SK; Kim TB; Lee EK
J Allergy Clin Immunol Pract; 2019; 7(8):2642-2652.e3. PubMed ID: 31108218
[TBL] [Abstract][Full Text] [Related]
39. Review: Pharmacological treatment of airway remodeling: inhaled corticosteroids or antileukotrienes?
Riccioni G; Di Ilio C; D'Orazio N
Ann Clin Lab Sci; 2004; 34(2):138-42. PubMed ID: 15228224
[TBL] [Abstract][Full Text] [Related]
40. Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment.
Turner S; Francis B; Vijverberg S; Pino-Yanes M; Maitland-van der Zee AH; Basu K; Bignell L; Mukhopadhyay S; Tavendale R; Palmer C; Hawcutt D; Pirmohamed M; Burchard EG; Lipworth B;
J Allergy Clin Immunol; 2016 Jul; 138(1):107-113.e5. PubMed ID: 26774659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
